Related Experiment Video

Updated: Apr 9, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K

The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas

Ruth Nussinov1, Serena Muratcioglu2, Chung-Jung Tsai3

  • 1Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, NCI at Frederick, Frederick, Maryland. Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. nussinor@helix.nih.gov.

Molecular Cancer Research : MCR
|June 19, 2015
PubMed

Insights

Calmodulin (CaM) selectively binds to oncogenic KRAS4B, promoting cancer cell growth. Targeting this KRAS4B/CaM interaction may offer a novel therapeutic strategy for adenocarcinomas.

Area of Science:

  • Molecular oncology
  • Cell signaling pathways

Background:

  • KRAS4B is a key oncogenic driver in adenocarcinomas, particularly pancreatic ductal adenocarcinoma (PDAC).
  • The precise mechanisms by which KRAS4B initiates and promotes ductal cancers remain incompletely understood.
  • Elevated intracellular calcium levels are a hallmark of many adenocarcinomas.

Purpose of the Study:

  • To investigate the role of calmodulin (CaM) in KRAS4B-mediated adenocarcinoma development.
  • To elucidate the mechanism by which CaM interacts with KRAS4B and influences downstream signaling.
  • To explore potential therapeutic strategies targeting the KRAS4B-CaM interaction.

Main Methods:

  • The study focuses on the selective binding of CaM to GTP-bound KRAS4B.
  • It proposes a mechanism involving Ca(2+)/CaM in recruiting and activating PI3Kα at the cell membrane.
  • The research integrates signaling through MAPK (Raf/MEK/ERK) and PI3K/Akt pathways.

Main Results:

  • Calmodulin selectively binds to GTP-bound KRAS4B, but not other Ras isoforms.
  • Ca(2+)/calmodulin is proposed to promote PI3Kα/Akt signaling by recruiting and activating PI3Kα.
  • This interaction explains KRAS4B's specific role in ductal carcinomas (PDAC, CRC, lung cancer) and elevated calcium levels.

Conclusions:

  • Calmodulin plays a critical, previously overlooked role in KRAS4B-driven adenocarcinomas.
  • CaM contributes to cancer initiation and progression via both PI3Kα/Akt and MAPK pathways.
  • Targeting the KRAS4B/CaM/PI3Kα complex presents a promising adenocarcinoma-specific therapeutic avenue.

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.9K
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

10.1K

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K